Novo Nordisk

Corporate Details

ISIN(s):

DK0062498333 (+1 more)

LEI:

549300DAQ1CVT6CXN342

Country:

Denmark

Address:

Novo Alle 1, 2880 Bagsværd

Website:

https://www.novonordisk.com/

Sector:

Health Care

Industry:

Biotechnology

Description

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 49,300 people in 80 countries and markets its products in around 170 countries. For more information, visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.